Pages with the fewest revisions

Jump to: navigation, search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Vitamin D-binding protein‏‎ (1 revision)
  2. Complement component C8 gamma chain‏‎ (1 revision)
  3. TG2 reactive residues (Insulin)‏‎ (1 revision)
  4. Hemopexin‏‎ (1 revision)
  5. 14-3-3 protein beta/alpha‏‎ (1 revision)
  6. Actin (FXIIIa)‏‎ (1 revision - redirect page)
  7. Apolipoprotein C-I‏‎ (1 revision)
  8. Coiled-coil domain-containing protein 126‏‎ (1 revision)
  9. Vitamin K-dependent protein C‏‎ (1 revision)
  10. Protein synthesis initiation factor 5A‏‎ (1 revision)
  11. Complement component C9‏‎ (1 revision)
  12. Dipeptidase 2‏‎ (1 revision)
  13. TG2 reactive residues (Actin)‏‎ (1 revision)
  14. TG2 reactive residues (Melittin)‏‎ (1 revision)
  15. Heparin cofactor 2‏‎ (1 revision)
  16. IgGFc-binding protein‏‎ (1 revision)
  17. 14-3-3 protein theta‏‎ (1 revision)
  18. K116, K125 (Histone H2B)‏‎ (1 revision)
  19. Apolipoprotein C-II‏‎ (1 revision)
  20. Minor TG2 reactive residues (Fibrinogen gamma)‏‎ (1 revision)
  21. Next to BRCA1 gene 1 protein‏‎ (1 revision)
  22. Thromboxane A2 receptor‏‎ (1 revision)
  23. Carboxypeptidase N catalytic chain‏‎ (1 revision)
  24. Collagen‏‎ (1 revision)
  25. Vitamin K-dependent protein S‏‎ (1 revision)
  26. Complement factor B‏‎ (1 revision)
  27. Sequestosome-1‏‎ (1 revision)
  28. TG2 reactive residues (Midkine)‏‎ (1 revision)
  29. Tetranectin‏‎ (1 revision)
  30. Ig alpha-1 chain C region‏‎ (1 revision)
  31. 26S proteasome non-ATPase regulatory subunit 4‏‎ (1 revision)
  32. Insulin-like growth factor-binding protein 6‏‎ (1 revision)
  33. Keratin, type II cytoskeletal 1‏‎ (1 revision)
  34. Apolipoprotein C-III‏‎ (1 revision)
  35. Monocyte differentiation antigen CD14‏‎ (1 revision)
  36. Carboxypeptidase N subunit 2‏‎ (1 revision)
  37. Uteroglobin‏‎ (1 revision)
  38. Vitamin K-dependent protein Z‏‎ (1 revision)
  39. Complement factor D‏‎ (1 revision)
  40. Drebrin-like protein‏‎ (1 revision)
  41. TG2 reactive residues (BHMT)‏‎ (1 revision)
  42. Glucosidase 2 subunit beta‏‎ (1 revision)
  43. TG2 reactive residues (Parkin)‏‎ (1 revision)
  44. Hepatocyte growth factor-like protein‏‎ (1 revision)
  45. Ig alpha-2 chain C region‏‎ (1 revision)
  46. Insulin-like growth factor-binding protein complex acid labile subunit‏‎ (1 revision)
  47. Keratin intermediate filaments‏‎ (1 revision)
  48. Apolipoprotein D‏‎ (1 revision)
  49. C-type lectin domain family 11 member A‏‎ (1 revision)
  50. Phosphatidylinositol-glycan-specific phospholipase D‏‎ (1 revision)
  51. Cartilage oligomeric matrix protein‏‎ (1 revision)
  52. Vitronectin‏‎ (1 revision)
  53. Proteoglycan 4‏‎ (1 revision)
  54. Complement factor H‏‎ (1 revision)
  55. Small ubiquitin-related modifier 1‏‎ (1 revision)
  56. TG2 reactive residues (C1 inhibitor)‏‎ (1 revision)
  57. TG2 reactive residues (Phospholipase A2)‏‎ (1 revision)
  58. Hepatocyte growth factor activator‏‎ (1 revision)
  59. Ig delta chain C region‏‎ (1 revision)
  60. 72 kDa type IV collagenase‏‎ (1 revision)
  61. Afamin‏‎ (1 revision)
  62. Apolipoprotein E‏‎ (1 revision)
  63. Beta-2-glycoprotein 1‏‎ (1 revision)
  64. C-type mannose receptor 2‏‎ (1 revision)
  65. Transcription factor AP-1‏‎ (1 revision)
  66. Platelet-derived growth factor receptor beta‏‎ (1 revision)
  67. Proto-oncogene tyrosine-protein kinase Src‏‎ (1 revision)
  68. Complement factor I‏‎ (1 revision)
  69. E3 SUMO-protein ligase PIAS4‏‎ (1 revision)
  70. Eukaryotic translation initiation factor 5A-1‏‎ (1 revision)
  71. TG2 reactive residues (Cytochrome C)‏‎ (1 revision)
  72. Glutathione S-transferase P‏‎ (1 revision)
  73. Ig heavy chain V-III region BRO‏‎ (1 revision)
  74. A-kinase anchor protein 13‏‎ (1 revision)
  75. Low-density lipoprotein receptor-related protein 6 (interaction partner)‏‎ (1 revision)
  76. Apolipoprotein E (TG2 Substrate)‏‎ (1 revision)
  77. Phospholipase A2‏‎ (1 revision)
  78. Platelet glycoprotein Ib alpha chain‏‎ (1 revision)
  79. Collectin-11‏‎ (1 revision)
  80. TG2 reactive residues (RAP)‏‎ (1 revision)
  81. Alpha-1B-glycoprotein‏‎ (1 revision)
  82. Lumican‏‎ (1 revision)
  83. Apolipoprotein F‏‎ (1 revision)
  84. C4b-binding protein beta chain‏‎ (1 revision)
  85. Procarboxypeptidase B/U‏‎ (1 revision)
  86. Serum paraoxonase/arylesterase 1‏‎ (1 revision)
  87. Ficolin-3‏‎ (1 revision)
  88. TG2 reactive residues (RhoA)‏‎ (1 revision)
  89. Ig kappa chain V-III region SIE‏‎ (1 revision)
  90. Alpha-1B adrenergic receptor‏‎ (1 revision)
  91. Apolipoprotein L1‏‎ (1 revision)
  92. Osteopontin‏‎ (1 revision)
  93. Complement C1r subcomponent‏‎ (1 revision)
  94. Ras-related C3 botulinum toxin substrate 1‏‎ (1 revision)
  95. Sex hormone-binding globulin‏‎ (1 revision)
  96. Filaggrin‏‎ (1 revision)
  97. HIV-1 aspartyl protease‏‎ (1 revision)
  98. TG2 reactive residues (S100A10)‏‎ (1 revision)
  99. Histone H1‏‎ (1 revision)
  100. Ig lambda-1 chain C regions‏‎ (1 revision)
  101. Inter-alpha-trypsin inhibitor heavy chain H3‏‎ (1 revision)
  102. Apolipoprotein M‏‎ (1 revision)
  103. Transforming growth factor-beta-induced protein ig-h3‏‎ (1 revision)
  104. Coagulation factor IX‏‎ (1 revision)
  105. Vasorin‏‎ (1 revision)
  106. Complement C1r subcomponent-like protein‏‎ (1 revision)
  107. Complement C2‏‎ (1 revision)
  108. TG2 reactive residues (GAPDH)‏‎ (1 revision)
  109. Ig mu chain C region‏‎ (1 revision)
  110. Inter-alpha-trypsin inhibitor heavy chain H4‏‎ (1 revision)
  111. Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2‏‎ (1 revision)
  112. N-acetylglucosamine-1-phosphotransferase subunit gamma‏‎ (1 revision)
  113. Phospholipid transfer protein‏‎ (1 revision)
  114. Retinoblastoma-associated protein‏‎ (1 revision)
  115. DNAJA1‏‎ (1 revision)
  116. SPARC-like protein 1‏‎ (1 revision)
  117. Small proline rich proteins SPRs-1‏‎ (1 revision)
  118. TG2 reactive residues (GST)‏‎ (1 revision)
  119. TG2 reactive residues (S100A7)‏‎ (1 revision)
  120. Alpha-2 macroglobulin (FXIIIa)‏‎ (1 revision - redirect page)
  121. Lipoprotein‏‎ (1 revision - redirect page)
  122. Mannan-binding lectin serine protease 1‏‎ (1 revision)
  123. N-acetylmuramoyl-L-alanine amidase‏‎ (1 revision)
  124. Beta lactoglobulin‏‎ (1 revision)
  125. Coagulation factor X‏‎ (1 revision)
  126. Properdin‏‎ (1 revision)
  127. Complement C4-B‏‎ (1 revision)
  128. Retinoblastoma protein‏‎ (1 revision)
  129. DNAJA1 (TG2 substrate)‏‎ (1 revision)
  130. TG2 reactive residues (Glucagon)‏‎ (1 revision)
  131. Haptoglobin‏‎ (1 revision)
  132. TG2 reactive residues (Synuclein)‏‎ (1 revision)
  133. Histone H2B type 1-C/E/F/G/I‏‎ (1 revision)
  134. A disintegrin and metalloproteinase with thrombospondin motifs 13‏‎ (1 revision)
  135. Intercellular adhesion molecule 2‏‎ (1 revision)
  136. Antithrombin-III‏‎ (1 revision)
  137. Melanocyte protein PMEL‏‎ (1 revision)
  138. Oxytocin receptor‏‎ (1 revision)
  139. Tubulin beta-1 chain‏‎ (1 revision)
  140. Coagulation factor XI‏‎ (1 revision)
  141. Protein HEG homolog 1‏‎ (1 revision)
  142. Selenoprotein P‏‎ (1 revision)
  143. TG2 reactive residues (Histone H2A)‏‎ (1 revision)
  144. Heat shock 70 kDa protein 1-like‏‎ (1 revision)
  145. TG2 reactive residues (Thymosin)‏‎ (1 revision)
  146. Histone H2B type 1-C/E/F/G/I (TG2 substrate)‏‎ (1 revision)
  147. Alpha-2 plasmin inhibitor‏‎ (1 revision)
  148. Apolipoprotein(a)‏‎ (1 revision)
  149. Attractin‏‎ (1 revision)
  150. Calmodulin‏‎ (1 revision)
  151. Plasma kallikrein‏‎ (1 revision)
  152. Coagulation factor XII‏‎ (1 revision)
  153. Protein MENT‏‎ (1 revision)
  154. Complement component C6‏‎ (1 revision)
  155. Desmoplakin‏‎ (1 revision)
  156. Small proline rich proteins SPRs-2‏‎ (1 revision)
  157. Galectin-3-binding protein‏‎ (1 revision)
  158. Heat shock cognate 71 kDa protein‏‎ (1 revision)
  159. TG2 reactive residues (Ubiquitin)‏‎ (1 revision)
  160. Histone H3.1‏‎ (1 revision)
  161. Apolipoprotein A-II‏‎ (1 revision)
  162. Plasma protease C1 inhibitor‏‎ (1 revision)
  163. Complement component C7‏‎ (1 revision)
  164. Fibrinogen beta chain‏‎ (1 revision)
  165. Heat shock protein beta-6‏‎ (1 revision)
  166. Hyaluronan-binding protein 2‏‎ (1 revision)
  167. Insulin-like growth factor-binding protein-3‏‎ (1 revision)
  168. Neurogenic locus notch homolog protein 2‏‎ (1 revision)
  169. Peptidase inhibitor 16‏‎ (1 revision)
  170. Plasminogen‏‎ (1 revision)
  171. Coagulation factor XIII B chain‏‎ (1 revision)
  172. Complement component C8 beta chain‏‎ (1 revision)
  173. Fibrinogen gamma chain‏‎ (1 revision)
  174. Hemoglobin subunit alpha‏‎ (1 revision)
  175. Histone octamer (kinase)‏‎ (1 revision)
  176. Calreticulin‏‎ (1 revision)
  177. S100A10‏‎ (2 revisions)
  178. Seminal vesicle secretory protein 3‏‎ (2 revisions)
  179. Small proline rich proteins SPRs-3‏‎ (2 revisions)
  180. Carboxypeptidase B2‏‎ (2 revisions)
  181. Hornerin‏‎ (2 revisions)
  182. Alpha lactalbumin‏‎ (2 revisions)
  183. Bcl-2 homologous antagonist/killer‏‎ (2 revisions)
  184. C-1-tetrahydrofolate synthase‏‎ (2 revisions)
  185. Peroxiredoxin-1‏‎ (2 revisions)
  186. Dispase autolysis inducing protein (DAIP)‏‎ (2 revisions)
  187. Fibronectin‏‎ (2 revisions)
  188. TG2 reactive residues (Annexin I)‏‎ (2 revisions)
  189. Adhesion G-protein coupled receptor G1‏‎ (2 revisions)
  190. Plasmodium falciparum liver stage antigen-1‏‎ (2 revisions)
  191. S100A11‏‎ (2 revisions)
  192. Ser/Thr protein phosphatase 2A‏‎ (2 revisions)
  193. Hsp27‏‎ (2 revisions)
  194. Adipocyte plasma membrane-assoiated protein‏‎ (2 revisions)
  195. Serine protease inhibitor Kazal-type 6‏‎ (2 revisions)
  196. Myoferlin‏‎ (2 revisions)
  197. Nucleophosmin‏‎ (2 revisions)
  198. Caspase-3‏‎ (2 revisions)
  199. Collagen alpha-1 (XVIII)‏‎ (2 revisions)
  200. TG2 reactive residues (Plasminogen)‏‎ (2 revisions)
  201. Myosin‏‎ (2 revisions)
  202. Cathepsin D‏‎ (2 revisions)
  203. Q4, K10 (Phospholipase A2)‏‎ (2 revisions)
  204. S100A4‏‎ (2 revisions)
  205. Lactadherin‏‎ (2 revisions)
  206. Color codes‏‎ (2 revisions)
  207. RAP - Alpha-2 macroglobulin related protein‏‎ (2 revisions)
  208. TG2 reactive residues (Elafin)‏‎ (2 revisions)
  209. Glycogen debranching enzyme‏‎ (2 revisions)
  210. ADP/ATP translocase 1‏‎ (2 revisions)
  211. Lysozyme C‏‎ (2 revisions)
  212. TG2 reactive residues (Fibrinogen gamma)‏‎ (2 revisions)
  213. Zyxin‏‎ (2 revisions)
  214. Ras GTPase-activating-like protein‏‎ (2 revisions)
  215. Single-stranded DNA-bindig protein‏‎ (2 revisions)
  216. Suprabasin‏‎ (2 revisions)
  217. TG2 reactive residues (S100A11)‏‎ (2 revisions)
  218. Histone H1 (kinase)‏‎ (2 revisions)
  219. Major vault protein‏‎ (2 revisions)
  220. Very long-chain specific acyl-CoA dehydrogenase‏‎ (2 revisions)
  221. Prolow-density lipoprotein receptor-related protein 1‏‎ (2 revisions)
  222. Antileukoproteinase‏‎ (2 revisions)
  223. Oxysterol-binding protein‏‎ (2 revisions)
  224. CD98 antigen/4F2 cell-surface antigen heavy chain‏‎ (2 revisions)
  225. Tubulin alpha‏‎ (2 revisions)
  226. Phosphorilated residues (pRB)‏‎ (2 revisions)
  227. Vimentin‏‎ (2 revisions)
  228. Fibrinogen alpha chain‏‎ (2 revisions)
  229. Lipoprotein A‏‎ (2 revisions)
  230. NADH-cytochrome b5 reductase 3‏‎ (2 revisions)
  231. Complement C8 alpha chain‏‎ (2 revisions)
  232. Tumor protein D54‏‎ (2 revisions)
  233. TG2 reactive residues (Histone H2B)‏‎ (2 revisions)
  234. Involucrin‏‎ (2 revisions)
  235. Calnexin‏‎ (2 revisions)
  236. Seminal vesicle secretory protein 1‏‎ (2 revisions)
  237. Enolase‏‎ (2 revisions)
  238. TG2 reactive residues (Histone H3)‏‎ (2 revisions)
  239. Long-chain-fatty-acid-CoA ligase‏‎ (2 revisions)
  240. Apolipoprotein A-IV‏‎ (2 revisions)
  241. Type I collagen‏‎ (2 revisions)
  242. TGM reactive residues (lactalbumin)‏‎ (2 revisions)
  243. Alpha-gliadin‏‎ (2 revisions)
  244. Loricrin‏‎ (2 revisions)
  245. Apolipoprotein B-100‏‎ (2 revisions)
  246. Microtubule-associated protein tau‏‎ (2 revisions)
  247. UDP-glucose:glycoprotein glucosyltransferase 1‏‎ (2 revisions)
  248. Coatomer‏‎ (2 revisions)
  249. Protein kinase C delta type‏‎ (3 revisions)
  250. Talin‏‎ (3 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)